Trends in Pharmaceuticals and Nanotechnology (e-ISSN: 2582-4457) https://matjournals.net/pharmacy/index.php/TPNT <p><strong>TPN</strong> is bi-annually peer review Journal. It is with a wide scope in the arena of pharmaceutical sciences covers the topics intended to be of interest to a broad audience of pharmaceutical professionals and ideally placed to serve the needs of their readers. This Journal deals in the field of nanotechnology and cover the topics intended to be of interest to a broad audience of Nanotechnology in pharmacy. This Journal mainly focus on Nanotechnology, Nanomedicine, Pharmaceutical Technology, Pharmaceutics, Drug Processing, Nanotechnological intervention, Nanomaterial.</p> en-US Fri, 13 Feb 2026 09:54:02 +0000 OJS 3.3.0.8 http://blogs.law.harvard.edu/tech/rss 60 Breaking Through Challenges in Nanoparticle-Mediated Drug Delivery https://matjournals.net/pharmacy/index.php/TPNT/article/view/341 <p><em>Nanoparticle-based drug delivery systems provide several important advantages, such as targeted drug delivery, controlled drug release, and enhanced bioavailability. Despite their strong therapeutic potential, several challenges must be addressed before they can be widely used in clinical applications. One major issue is the stability of nanoparticles, as problems such as aggregation, early drug leakage, and low drug-loading capacity can reduce their effectiveness. To address these challenges, advanced formulation approaches—including surface modification, encapsulation techniques, and self-assembly methods—have been developed. These strategies help improve structural stability, increase drug-carrying capacity, and enable sustained drug release. Another important concern is toxicity, especially during long-term use. The use of biocompatible, biodegradable, and stimuli-responsive materials has shown promise in reducing harmful effects, improving safety, and supporting efficient elimination from the body. Furthermore, techniques such as ligand-mediated targeting, magnetic guidance, and environment-responsive drug release are being explored to enhance delivery efficiency. Achieving consistent results also requires standardized manufacturing processes, reliable characterization techniques, and strict quality control during production. Overall, although nanoparticle-based drug delivery systems have great potential to transform modern therapeutics, their successful clinical translation depends on overcoming challenges related to stability, toxicity, targeted delivery, and large-scale manufacturing. Continuous advancements in material science, nanotechnology, and pharmaceutical engineering will play a crucial role in developing safe, efficient, and scalable nanoparticle-based therapies for future medical applications.</em></p> Lankapalli Srujani, Sadhu Venkateswara Rao, Kasagani Vasanthi, Ganthala Venkata Lekhya Sri, Gayathri Molleti, Bathula Swetha, Padmalatha Kantamaneni Copyright (c) 2026 Trends in Pharmaceuticals and Nanotechnology (e-ISSN: 2582-4457) https://matjournals.net/pharmacy/index.php/TPNT/article/view/341 Mon, 06 Apr 2026 00:00:00 +0000 Graphene-Based Biosensors for Real-Time Health Monitoring: A Novel Approach for Non-Invasive Continuous Physiological Tracking https://matjournals.net/pharmacy/index.php/TPNT/article/view/310 <p><span style="font-style: normal !msorm;"><em>Continuous health monitoring is transforming modern healthcare by enabling early diagnosis, personalized treatment, and preventive care. Among emerging sensing technologies, graphene-based biosensors have attracted significant attention due to their exceptional electrical conductivity, high surface-to-volume ratio, mechanical flexibility, and superior biocompatibility. These properties make graphene an ideal material for developing wearable, non-invasive biosensors capable of detecting biomarkers such as glucose and lactate in sweat or interstitial fluid (ISF). This paper presents a comprehensive system architecture for a graphene-based wearable biosensing platform integrated with low-power electronics and wireless communication for real-time physiological monitoring. The proposed system consists of a graphene functionalized electrochemical sensor patch, an analog front end (AFE) for signal conditioning, a microcontroller unit (MCU) for processing and temperature compensation, and a Bluetooth Low Energy (BLE) module for data transmission to a smartphone application. A detailed literature survey highlights advancements in graphene biosensors while identifying gaps in system integration, long-term stability, and power optimization. The proposed methodology addresses these limitations through modular hardware design and intelligent signal processing. Simulated results based on literature benchmarks demonstrate improvements in sensitivity, signal-to-noise ratio, and detection limits compared to existing wearable biosensors. The study confirms that graphene-based wearable platforms can provide reliable, continuous, and real-time biochemical monitoring, paving the way for next-generation digital healthcare systems.</em></span></p> Geetanjali Yogesh Lubal Copyright (c) 2026 Trends in Pharmaceuticals and Nanotechnology (e-ISSN: 2582-4457) https://matjournals.net/pharmacy/index.php/TPNT/article/view/310 Fri, 13 Feb 2026 00:00:00 +0000 Emerging Technologies in Digital Medicine: Wearables, AI, and Smart Health Monitoring https://matjournals.net/pharmacy/index.php/TPNT/article/view/327 <p><em>Digital medicine represents a transformative approach to healthcare by integrating advanced digital technologies with medical science to improve disease prevention, diagnosis, monitoring, and treatment. The rapid development of wearable health devices, artificial Intelligence (AI), machine learning algorithms, and smart biosensing systems has significantly expanded the possibilities for continuous health monitoring and personalized medical care. The objective of this article is to review the recent technological advancements in digital medicine and examine how these innovations contribute to modern healthcare systems. This study analyzes various digital health technologies including wearable activity trackers, smartwatches, artificial intelligence–based medical imaging tools, robotic-assisted surgical systems, and emerging biosensor technologies such as electronic digital tattoos. Wearable devices enable the continuous measurement of physiological parameters such as heart rate, physical activity levels, sleep patterns, and other health indicators, thereby facilitating remote patient monitoring and early detection of potential health risks. Artificial intelligence and deep learning techniques have demonstrated remarkable capabilities in medical imaging analysis, improving diagnostic accuracy and supporting clinical decision-making processes. Robotic-assisted surgical technologies further enhance precision and efficiency in complex surgical procedures, reducing human error and improving patient outcomes. Additionally, novel biosensing technologies offer new possibilities for non-invasive and real-time physiological monitoring. The findings indicate that digital medicine technologies have the potential to significantly enhance healthcare accessibility, diagnostic accuracy, and patient-centered care. However, challenges related to data privacy, ethical considerations, technological reliability, and regulatory policies remain important issues that must be addressed. Overall, digital medicine is expected to play a crucial role in shaping the future of healthcare by enabling more efficient, data-driven, and personalized medical practices.</em></p> Anu Yousef, Rose Maria P. J, Aiswarya Suresh, Anu Jayamol Mathew Copyright (c) 2026 Trends in Pharmaceuticals and Nanotechnology (e-ISSN: 2582-4457) https://matjournals.net/pharmacy/index.php/TPNT/article/view/327 Tue, 24 Mar 2026 00:00:00 +0000